Lecture 2 Flashcards
What is affinity?
The binding of a drug to a receptor.
Describe Kd?
Affinity constant - this is the concentration of the ligand that will bind to 50% of the substrate.
What happens if affinity is high?
You will need less concentration of ligand to bind to the substrate - therefore concentration will be low. This is known as a smaller Kd.
Describe affinity vs Biological response?
When you look at biological response curve you are not getting a measure of direct drug binding to the receptor. This is due to occupancy and effect are not always completely proportional. Affinity and ability to produce an effect don’t always line up. Biological effect could be measuring anything (the further away from a receptor then you have other systems interacting with the drug).
Describe Biological Response curves?
A biological response can be anything - change in BP, ion channel opening or the activation of an enzyme. These can be measured and plotted as a concentration response curve. We look at the
Describe the effect of a drug?
This is defined by the maximal effect (EMAX) and the EC50 (the concentration in which the drug produces a 50% result).
Describe potency?
EC50 is the effective concentration of an agonist that produces 50% of the maximal response. When potency is high EC50 will be low (due to less drug that is needed to produce an effect).
Describe efficacy?
This is the maximum affect a drug can produce.
What is an agonist drug?
A drug with positive efficacy will activate a receptor to promote cellular response.
What is an inverse agonist drug?
A drug which produces a decrease response.
What is an antagonist drug?
A drug that binds to the receptor but does not produce a conformational change. This is to prevent the natural agonist at the receptor.
What is the difference between full and partial agonists?
Full - drugs that produce the maximum tissue response.
Partial - drugs that produce less than the maximum response. These agonists cannot produce the maximal response even at 100% receptor occupancy. Basically the ligand binds to the receptor but does not cause the full drive of conformational change. on the receptor.
Describe antagonism?
Bind to a receptor but don’t activate or inactivate a receptor. Have affinity but zero efficacy.
Describe reversible competitive antagonism?
Binds non-covalently to the receptor. Competes for the orthosteric binding site. This will stop the agonist ligand binding to the receptor.
What happens to the antagonist if you continue to add agonist?
The agonist will outcompete the antagonist. Will see an effect. You will continue to move the curve to the right.